YARA YÖNETİMİNDE “TIME” YAKLAŞIM

Öz

Kronik yaraların yönetiminde yara durumunun değerlendirilmesinin yanında, yaranın iyileşmesini önleyen moleküler ve hücresel anormalliklerin anlaşılması önem taşımaktadır. Yara yatağı hazırlığı kavramı, doğal iyileşme sürecini etkileyen etmenleri ortadan kaldırma ve ileri terapi tekniklerinin etkilerini arttırmaya yönelik sistematik bir yaklaşım gerektirmektedir. Yara yatağı hazırlığı ile ilgili bu makalede bu kavramların gelişimini ve “TIME”- doku (tissue), enfeksiyon/inflamasyon (infection), nem (moisture) ve yara kenarı (edge) akronimini kullanarak sistematik yara yönetiminin nasıl uygulanacağı açıklanmaktadır.

Anahtar Kelimeler

• Debridman, büyüme faktörleri, enfeksiyon, nem, yara yatağı hazırlığı, “TIME” yaklaşımı

Kaynakça

1. Ayello EA, Cuddigan JE (2004). Conquer chronic wounds with wound bed preparation. The Journal for Nurse Practitioners 29(3):8-25.
2. Coerper S, Beckert S, Becker HD (2004). Possible interventions in impaired wound healing. Chirurgia 75(5):471-6.
3. Collier M (2002). Wound bed preparation. Journal of Wound Care 11(1):28.
4. Collier M (2003). Wound bed preparation: theory to practice. Nursing Standard 21- 27;17(36):45-52.
5. Cooper RA (2004). Understanding wound infection. A position document, published by MEP Ltd, London. Available from www.ewma.org (erişim tarihi:28.11.2005).
6. Cutting KF (1998). Identification of infection in granulating wounds by registered nurses. Journal of Clinical Nursing 7:539-546.
7. Cutting KF, White RJ, Mahoney P et al. (2004). Clinical identification of wound infection: A delphi approach. A position document, published by MEP Ltd, London. Available from www.ewma.org (erişim tarihi:15.12.2005).
8. Douglass J (2003). Wound bed preparation: A systematic approach to chronic wounds. British Journal of Community Nursing 8(6 Suppl):26-34.

9. Dowsett C (2002). The role of the nurse in wound bed preparation. Nursing Standard 16(44):69-76.
10. Dowsett C, Ayello E (2004). TIME principles of chronic wound bed preparation and treatment. British Journal of Nursing 12- 8;13(15):16-23.
11. Falanga V (2000). Classifications for wound bed preparation and stimulation of chronic wounds. Wound Repair and Regeneration 8(5):347-52.
12. Falanga V (2003). Wound bed preparation: future approaches. Ostomy Wound Management 49(5A Suppl):30-33.
13. Falanga V (2004a). The chronic wound: Impaired healing and solutions in the context of wound bed preparation. Blood Cells, Molecules & Diseases 32(1):88-94.
14. Falanga V (2004b). Wound bed preparation: Science applied to practice. A position document, published by MEP Ltd, London Available from www.ewma.org (erişim tarihi:15.12.2005)
15. Fletcher F (2003). The benefits of applying wound-bed preparation into practice. Journal of Wound Care 12(9):347-9.
16. Hess CT, Kirsner RS (2003).Uncover the latest techniques in wound bed preparation. Nursing Management 34(12):54-6.
17. Kannon G, Garrett A (1995). Moist wound healing with occlusive dressings: A clinical review. Dermatologic Surgery 21:583-90.
18. Kirsner R (2003) Wound bed preparation. Ostomy Wound Management 49 Suppl:2-3.
19. Krasner DL (2001). How to prepare the wound bed. Ostomy Wound Management 47(4):59-61.
20. Romanelli M, Flanagan M (2005). After TIME: Wound bed preparation for pressure ulcers. European Wound Management Association Journal 5(1):22-30.
21. Romanelli M, Mastronicola D (2002). The role of wound-bed preparation in managing chronic pressure ulcers. Journal of Wound Care 11(8):305-10.
22. Schultz GS, Barillo DJ, Mozingo DW, et al. (2004). Wound bed preparation and A brief history of TIME. International Wound Journal 1(1):19-32.
23. Schultz GS, Sibbald RG, Falanga V et al. (2003). Wound bed preparation: A systematic approach to wound management. Wound Repair and Regeneration11:1-28.
24. Sibbald RG, Orsted H, Schultz GS et al. (2003). International wound bed preparation advisory board preparing the wound bed. Focus on infection and inflammation. Ostomy Wound Management 49(11):23-51. Smiell JM, Wieman TJ, Steed DL et al. (1999). Efficacy and safety of becaplermin (Recombinant human platelet-derived growth factor-BB) in patient with non- healing, lower extremity diabetic ulcers: A combined analysis of four randomized studies. Wound Repair and Regeneration 7:335-46.
25. Vanscheidt W, Ukat A, Hauss F (2005). International wound bed preparation advisory board systematic management of chronic wounds employing the TIME concept.
26. Wochenschrift Fortschritte der Medizin 147 (Suppl 3):119-26.